Skip to main content

and
Your search also matched 7 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer

Include preview-only content
  1. Article

    Open Access

    A combinatorial genetic strategy for exploring complex genotype–phenotype associations in cancer

    Available genetically defined cancer models are limited in genotypic and phenotypic complexity and underrepresent the heterogeneity of human cancer. Here, we describe a combinatorial genetic strategy applied t...

    Shan Li, Alicia Wong, Huiyun Sun, Vipul Bhatia, Gerardo Javier in Nature Genetics (2024)

  2. Article

    Open Access

    Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer

    To assess the association of patient age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (MIBC).

    David D’Andrea, Peter C. Black, Homayoun Zargar in World Journal of Urology (2021)

  3. Article

    Open Access

    A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture

    Bladder cancer is among the most prevalent cancers worldwide. Currently, few bladder cancer models have undergone thorough characterization to assess their fidelity to patient tumors, especially upon propagati...

    Elise Y. Cai, Jose Garcia, Yuzhen Liu, Funda Vakar-Lopez in Scientific Reports (2021)

  4. Article

    Open Access

    Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis

    Muscle-invasive bladder cancer (MIBC) is a heterogeneous disease, and gene expression profiling has identified several molecular subtypes with distinct biological and clinicopathological characteristics. While...

    Joep J. de Jong, Yang Liu, A. Gordon Robertson, Roland Seiler in Genome Medicine (2019)

  5. Article

    Open Access

    Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy

    Identifying the subset of patients with clinically localized prostate cancer (PCa) at the highest risk of recurrence remains challenging, and better prognostic markers are needed. Gleason score is the best pre...

    Milan S. Geybels, Jonathan L. Wright, Marina Bibikova in Clinical Epigenetics (2016)

  6. Article

    Open Access

    Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study

    Metformin is a commonly used medication for type II diabetes mellitus. Epidemiologic studies have suggested a decreased relative risk of cancer with metformin use, and preclinical studies of prostate cancer (P...

    Jonathan L. Wright, Janet L. Stanford in Cancer Causes & Control (2009)